AbCellera Biologics Inc. (ABCL)
NASDAQ·Healthcare·Biotechnology
$10.90
+4.16%
Mkt Cap $3.49B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (9 analysts)
$7.50
Range $7.00 – $8.00
Implied Upside
-31.2%
Consensus $7.50 vs current $10.90
NASDAQ·Healthcare·Biotechnology
$10.90
+4.16%
Mkt Cap $3.49B
Buy
4
Hold
0
Sell
0
Price Target (9 analysts)
$7.50
Range $7.00 – $8.00
-31.2%
Consensus $7.50 vs current $10.90